Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years

Authors

Institutions

Publication Details

Journal
JAMA
Published
2025-05-07
DOI
https://doi.org/10.1001/jama.2025.5646
Citations
24
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
32.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years

Weiping Deng, Benoît Callendret, Christine A. Shaw, Bethany Girard et al.
24 citations
JAMA
Influenza Virus Research Studies
32.50
article

Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years

Weiping Deng, Benoît Callendret, Christine A. Shaw, Bethany Girard, Kimball Johnson, Verónica Urdaneta, Lusiné Kostanyan, Amanda K. Rudman Spergel, Yamuna Devi Paila, Jacqueline Miller, Kristi Schaefers, Darshan Mehta, Lizbeth Carmona, José F. Cardona, Rituparna Das, Iris Wu, Jintanat Ananworanich, Melissa Sinkiewicz, Ivette Espinosa-Fernandez
article en
24 citations

Abstract

No abstract available for this paper.
JAMAVol. 333(22)
Moderna Therapeutics (United States) (US)
Good health and well-being
Openalex Percentile: Top 0%
Influenza Virus Research Studies
32.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.